Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Differentiated Thyroid Carcinoma”

229 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 229 results

Not applicableEnded earlyNCT02947399
What this trial is testing

Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal

Who this might be right for
Thyroid Cancer
Medstar Health Research Institute 16
Not applicableStudy completedNCT01840332
What this trial is testing

Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
University of Tartu 20
Testing effectiveness (Phase 2)UnknownNCT01471288
What this trial is testing

Effect of Carum Carvi on Thyroid Hormones and TSH Level

Who this might be right for
Thyroid Cancer Patients
Mashhad University of Medical Sciences 40
Not applicableUnknownNCT03700762
What this trial is testing

Application of Ultrasonic Gray-scale Ratio in Differentiating Benign From Malignant Thyroid Nodules.

Who this might be right for
Thyroid Nodule
First People's Hospital of Hangzhou 300
Not applicableStudy completedNCT03776123
What this trial is testing

Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

Who this might be right for
Renal Cell CarcinomaHepatocellular CarcinomaDifferentiated Thyroid Carcinoma
Ipsen 347
Not applicableStudy completedNCT01954134
What this trial is testing

P53 in Differentiated Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Cumhuriyet University 199
Not applicableEnded earlyNCT05014698
What this trial is testing

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

Who this might be right for
Differentiated Thyroid CancerThyroid Cancer, Nonmedullary
Nantes University Hospital 34
Not applicableEnded earlyNCT00926978
What this trial is testing

Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)

Who this might be right for
Thyroid Cancer
Medstar Health Research Institute 21
Not applicableUnknownNCT03416686
What this trial is testing

Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy

Who this might be right for
Differentiated Thyroid Cancer
Assistance Publique - Hôpitaux de Paris 18
Not applicableUnknownNCT02638077
What this trial is testing

Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China

Who this might be right for
Differentiated Thyroid Cancer
Huazhong University of Science and Technology 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT07016230
What this trial is testing

Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)

Who this might be right for
Metastatic/Locally Advanced Small-Cell Lung CancerMetastatic/Locally Advanced Poorly Differentiated NECMetastatic/Locally Advanced High-grade MTC
Gustave Roussy, Cancer Campus, Grand Paris
Testing effectiveness (Phase 2)Study completedNCT00104871
What this trial is testing

Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

Who this might be right for
Insular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+3 more
National Cancer Institute (NCI) 24
Very early researchLooking for participantsNCT06639191
What this trial is testing

[177Lu]Lu-AKIR001 First-in-human Study

Who this might be right for
Thyroid Gland Anaplastic CarcinomaPoorly Differentiated Thyroid CarcinomaCancer Head and Neck+3 more
Karolinska University Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT06959641
What this trial is testing

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

Who this might be right for
Locally Advanced Differentiated Thyroid Gland CarcinomaLocally Advanced Poorly Differentiated Thyroid Gland CarcinomaLocally Advanced Thyroid Gland Follicular Carcinoma+18 more
Northwestern University 33
Post-approval studies (Phase 4)UnknownNCT05466812
What this trial is testing

Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases

Who this might be right for
Thyroid Neoplasm FollicularBone Metastases
Peking Union Medical College Hospital 20
Large-scale testing (Phase 3)UnknownNCT02586337
What this trial is testing

Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)

Who this might be right for
Differentiated Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 113
Testing effectiveness (Phase 2)UnknownNCT01118065
What this trial is testing

Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Leiden University Medical Center 42
Testing effectiveness (Phase 2)Study completedNCT02702388
What this trial is testing

A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

Who this might be right for
Thyroid Cancer
Eisai Inc. 241
Not applicableUnknownNCT02665325
What this trial is testing

Cognitive Functions During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma

Who this might be right for
Cognitive Impairment
The Affiliated Hospital of Inner Mongolia Medical University 100
Testing effectiveness (Phase 2)Study completedNCT02393690
What this trial is testing

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland Carcinoma+8 more
Academic and Community Cancer Research United 60
Load More Results
40